← Eichor
Study identifier: NCT06093672 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Condition: Polycythemia Vera  ·  Sponsor: Italfarmaco

PhasePhase 3
Planned participants220
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.

This description comes directly from the study's public registry record.

Talk to the study team

Maurizio Caserini  ·  +39 02 6443 1  ·  patientadvocacy@italfarmacogroup.com

Always discuss trial participation with your own doctor first.

Locations (90)

University of Alabama at BirminghamBirmingham, Alabama, United StatesNot Yet Recruiting
Emad Ibrahim, MD, IncRedlands, California, United StatesRecruiting
US Oncology IncEnglewood, Colorado, United StatesRecruiting
American Oncology Partners of Maryland, PABethesda, Maryland, United StatesRecruiting
Icahn School of Medicine at Mount SinaiNew York, New York, United StatesRecruiting
University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting
The Cleveland Clinic FoundationCleveland, Ohio, United StatesRecruiting
Oncology Associates of Oregon, P.C.Eugene, Oregon, United StatesRecruiting
MD Anderson Cancer CenterHouston, Texas, United StatesRecruiting
Texas Oncology (Webster) - USORHouston, Texas, United StatesRecruiting
Texas Oncology-Denison Cancer CenterSherman, Texas, United StatesRecruiting
University of Utah - Huntsman Cancer Institute - PPDSSalt Lake City, Utah, United StatesRecruiting

+ 78 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06093672